119 related articles for article (PubMed ID: 23240862)
1. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
2. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
[TBL] [Abstract][Full Text] [Related]
3. Metabolite signature of human malignant thyroid tissue: A systematic review and meta-analysis.
Razavi SA; Khorsand B; Salehipour P; Hedayati M
Cancer Med; 2024 Apr; 13(8):e7184. PubMed ID: 38646957
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning-Based Integrated Multiomics Characterization of Colorectal Cancer Reveals Distinctive Metabolic Signatures.
Zheng R; Su R; Fan Y; Xing F; Huang K; Yan F; Chen H; Liu B; Fang L; Du Y; Zhou F; Wang D; Feng S
Anal Chem; 2024 May; 96(21):8772-8781. PubMed ID: 38743842
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic characterization of colorectal cancer cell lines highlighting stage-specific alterations during cancer progression.
Yusof HM; Ab-Rahim S; Wan Ngah WZ; Nathan S; A Jamal AR; Mazlan M
Bioimpacts; 2021; 11(2):147-156. PubMed ID: 33842285
[No Abstract] [Full Text] [Related]
6. Analysis of cancer tissues by means of spectroscopic methods.
Pacholczyk B; Fabiańska A; Kusińska R; Potemski P; Kordek R; Jankowski S
Contemp Oncol (Pozn); 2012; 16(4):290-4. PubMed ID: 23788897
[TBL] [Abstract][Full Text] [Related]
7. The application of NMR-based metabonomics in neurological disorders.
Holmes E; Tsang TM; Tabrizi SJ
NeuroRx; 2006 Jul; 3(3):358-72. PubMed ID: 16815219
[TBL] [Abstract][Full Text] [Related]
8. Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies.
Mirnezami R; Jiménez B; Li JV; Kinross JM; Veselkov K; Goldin RD; Holmes E; Nicholson JK; Darzi A
Ann Surg; 2014 Jun; 259(6):1138-49. PubMed ID: 23860197
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer detection using targeted serum metabolic profiling.
Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Chiorean EG; Raftery D
J Proteome Res; 2014 Sep; 13(9):4120-30. PubMed ID: 25126899
[TBL] [Abstract][Full Text] [Related]
10. ¹H NMR-based metabolic profiling of human rectal cancer tissue.
Wang H; Wang L; Zhang H; Deng P; Chen J; Zhou B; Hu J; Zou J; Lu W; Xiang P; Wu T; Shao X; Li Y; Zhou Z; Zhao YL
Mol Cancer; 2013 Oct; 12(1):121. PubMed ID: 24138801
[TBL] [Abstract][Full Text] [Related]
11. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping.
Dona AC; Jiménez B; Schäfer H; Humpfer E; Spraul M; Lewis MR; Pearce JT; Holmes E; Lindon JC; Nicholson JK
Anal Chem; 2014 Oct; 86(19):9887-94. PubMed ID: 25180432
[TBL] [Abstract][Full Text] [Related]
12. Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.
Ni Y; Xie G; Jia W
J Proteome Res; 2014 Sep; 13(9):3857-70. PubMed ID: 25105552
[TBL] [Abstract][Full Text] [Related]
13. Tumor Tissue-Specific Biomarkers of Colorectal Cancer by Anatomic Location and Stage.
Cai Y; Rattray NJW; Zhang Q; Mironova V; Santos-Neto A; Muca E; Vollmar AKR; Hsu KS; Rattray Z; Cross JR; Zhang Y; Paty PB; Khan SA; Johnson CH
Metabolites; 2020 Jun; 10(6):. PubMed ID: 32575361
[TBL] [Abstract][Full Text] [Related]
14. A prospective analysis of mucosal microbiome-metabonome interactions in colorectal cancer using a combined MAS 1HNMR and metataxonomic strategy.
Kinross J; Mirnezami R; Alexander J; Brown R; Scott A; Galea D; Veselkov K; Goldin R; Darzi A; Nicholson J; Marchesi JR
Sci Rep; 2017 Aug; 7(1):8979. PubMed ID: 28827587
[TBL] [Abstract][Full Text] [Related]
15. Tissue Metabonomic Phenotyping for Diagnosis and Prognosis of Human Colorectal Cancer.
Tian Y; Xu T; Huang J; Zhang L; Xu S; Xiong B; Wang Y; Tang H
Sci Rep; 2016 Feb; 6():20790. PubMed ID: 26876567
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolic reprogramming in cancer cells.
Beloribi-Djefaflia S; Vasseur S; Guillaumond F
Oncogenesis; 2016 Jan; 5(1):e189. PubMed ID: 26807644
[TBL] [Abstract][Full Text] [Related]
17. The consensus molecular subtypes of colorectal cancer.
Guinney J; Dienstmann R; Wang X; de Reyniès A; Schlicker A; Soneson C; Marisa L; Roepman P; Nyamundanda G; Angelino P; Bot BM; Morris JS; Simon IM; Gerster S; Fessler E; De Sousa E Melo F; Missiaglia E; Ramay H; Barras D; Homicsko K; Maru D; Manyam GC; Broom B; Boige V; Perez-Villamil B; Laderas T; Salazar R; Gray JW; Hanahan D; Tabernero J; Bernards R; Friend SH; Laurent-Puig P; Medema JP; Sadanandam A; Wessels L; Delorenzi M; Kopetz S; Vermeulen L; Tejpar S
Nat Med; 2015 Nov; 21(11):1350-6. PubMed ID: 26457759
[TBL] [Abstract][Full Text] [Related]
18. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
